NCT02714400View on ClinicalTrials.gov

The Impact of Venlafaxine on Apnea Hypopnea Index in Obstructive Sleep Apnea

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions
Obstructive Sleep Apnea
Interventions
DRUG

Venlafaxine

Venlafaxine 50mg before sleep

DRUG

Placebo

One piece of placebo before sleep

Trial Locations (1)

92093

University of California, San Diego, San Diego

All Listed Sponsors
lead

University of California, San Diego

OTHER

NCT02714400 - The Impact of Venlafaxine on Apnea Hypopnea Index in Obstructive Sleep Apnea | Biotech Hunter | Biotech Hunter